|Articles|January 15, 2002
- BioPharm International-01-01-2002
- Volume 15
- Issue 1
Liposomes (a Review): Part Two, Drug Delivery Systems
by Suggy S. Chrai, R. Murari, and Imran Ahmad Good manufacturing processes require that lipid vesicles be reproducibly uniform in size, carry the drug in sufficient concentration, and remain stable for an acceptable shelf-life under varying temperatures. Following these guidelines improves the analytical processes that support biopharmaceutical drug development.
Advertisement
Articles in this issue
almost 24 years ago
Outsourcing Outlook: E-Sourcing, Internet Facilitates Flexible Collaborationalmost 24 years ago
Inside Washington: Biotechnology in the Limelight, the Year Aheadalmost 24 years ago
Your Vested Interests: The War of the Westalmost 24 years ago
Statistics for Laboratory Method Comparison Studiesalmost 24 years ago
From the Editor: Farewell to 2001 . . . Our Biotech Odyssey Continuesalmost 24 years ago
Information Age AuditsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Regulatory Challenges for Global Manufacturing of Vaccines
2
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
3
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
4
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
5
